Anzeige
Mehr »
Login
Dienstag, 29.11.2022 Börsentäglich über 12.000 News von 681 internationalen Medien
Breaking News! Rallye und Ausbruch die logische Konsequenz?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Endpoints News

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MoSanofi welcomes 500 staffers to new Paris HQ after €30M renovation
MoStada to place $50M+ investment in a new facility in Romania
MoUS seeks jail time for co-CEO of New England compounding center after deadly 2012 fungal outbreak
MoPfizer CEO under fire from UK watchdog over vaccine comments - report
MoFDA tells Catalent to fix issues at two manufacturing sites on its own
MoPost-Brexit UK trade report shows 'worrying' signs for life sciences
MoMerck's latest 'Why Vaccines' campaign seeks to better inform vaccine-hesitant moms
MoIndustry groups, CVS pick apart FDA's proposed pathway for generics to carve out OTC indications
MoFourth accelerated approval in Duchenne? Sarepta gets priority review for gene therapy amid FDA scrutiny
MoSan Diego biotech lands $120M to launch a slate of trials in neurosensory disorders
MoNearly a year after his SPAC combines with EQRx, Eli Casdin resigns from board
MoAxsome's approved depression drug clears Alzheimer's agitation trial months after Lundbeck-Otsuka duo
MoLilly joins in Series A extension of BeiGene-partnered mRNA biotech
MoIn new deal, AstraZeneca places small bet on 'critical but challenging' target
MoVaccine documents, young leaders and market turmoil: Endpoints' 10 biggest stories of 2022
MoSpectrum implodes after a harsh public slapdown and now a CRL from Richard Pazdur
SaBig Pharma's Twitter exodus; Merck wagers $1.35B on buyout; $3.5M gene therapy; and more
DoMIT researchers reveal DNA "Paste" tech behind latest gene editing startup
MiJ&J's Spravato pulls a PhIII win against Seroquel XR in treatment-resistant depression
MiSuspended California cell therapy manufacturing site hit with FDA warning letter over major quality concerns
MiRoivant's Dermavant debuts first-ever TV commercial for psoriasis cream Vtama
MiPharma renewable energy co-op sparks broader supplier push, follows Walmart's lead
MiFDA preps for DMD drug generics as Sarepta has yet to finish its confirmatory trial
MiGaming for pharma: Real Chemistry adds video game marketing to agency expertise
MiOne hurdle down? FDA won't hold adcomm for BioMarin's hemophilia gene therapy after all